Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA add-on crossover study in women with oral contraceptive-associated sexual dysfunction
2007-000013-10Phase 3Completed
- Sponsor
- Pantarhei Bioscience
- Start
- Jan 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dehydroepiandrosterone in female sexual dysfunction (FSD) and sexual dysfunction, sponsored by Pantarhei Bioscience. Primary endpoints: Sexual arousability, sexual desire, and frequency of sexual fantasies and Frequency of and sexual response to sexual activities. Started Jan 2007; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
female sexual dysfunction (FSD)sexual dysfunction
Beyond the preview
Go deeper on 2007-000013-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000013-10.